Education

• 1982 ~ 1987 PhD, Massachusetts Institute of Technology (Biology)
• 1977 ~ 1979 MS, KAIST (Biological Engineering)
• 1973 ~ 1977 BS, Seoul National University (Pharmacy)

Experience

• 2020 ~ Present Director General, Vaccine Innovative Technology ALliance (VITAL)-Korea
• 2023 ~ Present Chairman, Korea Advanced Center for Vaccine Development (KAVAD)
• 2022 ~ 2024 Chair, Division of Biotechnology, Science & Technology Advisory Board, Ministry of Foreign Affairs (MoFA), Korean Government
• 2022 ~ 2023 Chair, Infectious Disease R&D Organizations Council
• 2020 ~ 2023 Chair, COVID-19 Vaccine Pan-Government Strategic Plan, Korean Government
• 2021 ~ 2023 Member, Presidential Advisory Council of Science and Technology (PACST)
• 2013 ~ 2018 Director, Vaccine Translational Research Center
• 2001 ~ 2009 CEO, Protheon
• 1999 ~ 2002 Representative, Ad Hoc Group Meeting, Biological Weapons Convention (BWC) UN Conference
• 1998 ~ 2020 Professor, Department of Biotechnology, Yonsei Univ
• 1993 ~ 1998 Director, Institute of Biological Sciences, Hanhyo Institute of Technology
• 1992 ~ 1993 Scientist, Aviron, USA
• 1988 ~ 1992 Post-doc, University of Oxford, UK
• 1979 ~ 1982 Scientist, Korea Institute of Science and Technolog

Education

• 1995 ~ 2000 University of Chicago (BA in Economics)
• 2001 ~ 2008 Yonsei University College of Medicine (MD)
• 2009 ~ 2010 Johns Hopkins School of Public Health (MPH)
• 2013 ~ 2021 Yonsei University College of Medicine, Health Ethics and Law Division (PhD)

Experience

• 2022 ~ Present CSO, RIGHT Foundation
• 2017 ~ Present Adjunct Professor, Yonsei University School of Public Health
• 2013 ~ Present Member of the Board, Korea Society of Global Health
• 2019 ~ 2022 Representative Partner, Global Health & Development Partners (GHDP)
• 2011 ~ 2016 Health Advisor, KOICA HQ and Ghana Country Office
• 2008 ~ 2009 Medical Officer in Division of National Immunization Program, Korea CDC

Education

• 1984 ~ 1988 B.S. / Department of Biology, College of Natural Science, Korea University, Seoul Korea
• 1988 ~ 1990 M.S. / Department of Biology, College of Natural Science, Korea University Graduate School, Seoul Korea
• 1994 ~ 2000 Ph.D. / Department of Life Science, College of Natural Science, Chung-Ang University, Seoul Korea

Experience

• 2022 ~ Present Advisory member of Infectious Disease Policy Beauro, Seoul Metropolitan city, Korea
• 2022 ~ Present Committee member of Government-wide R&D Fund for Infectious Disease Research (GFID), Korea
• 2021 ~ Present Advisory member of Korea Pest Control Association, Korea
• 2006 ~ Present Full member, The American Society for Virology
• 1990 ~ Present Committee member, The Korean Society of Virology
• 1990 ~ 2019 Director, Researcher, Divisions of Influenza and respiratory viruses, Department of Virus Research, National Institute of Health, Korea
• 2004 ~ 2006 University of Nebraska Medical Center, NE, USA, Visiting Scientist
• 1996 ~ 1997 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan, Visiting Scientist
• 1994 ~ 1994NIID, Tokyo, Japan, “Polio Eradication Program”, WHO fellow

Education

• 2000 ~ 2006 PhD, Northwestern University Medical School
• 1996 ~ 1999 MSc, Seoul National University
• 1990 ~ 1996 BSc, Seoul National University

Experience

• 2013 ~ Present 전북대학교 (인수공통전염병연구소)
• 2011 ~ 2013 Presidential Postdoc, Novartis Institutes for Biomedical Research (NIBR)
• 2007 ~ 2011 Postdoc, University of California San Francisco

Topic

• Preparing for tomorrow’s pandemics today through the development of broadly active therapies

Summary

Topic

• Research on therapeutics development to emerging high-risk viruses

Summary

Topic

• Collaboration on infectious disease research using overseas research centers in the Philippines

Summary

• In our continuous effort to foster international cooperation for infectious disease research, the Philippines Research Institute for Tropical Medicine (RITM) and the Korea National Institute of Infectious Diseases (KNIID) signed a Memorandum of Understanding (MOU) last July 20, 2023. This agreement formalized the establishment of an overseas research hub in the Philippines, initiated by KNIID, where both institutions will maximize their strengths and resources. The primary objectives of this research hub are to enhance infectious disease studies by:
  1. Conducting cutting -edge research and development that aims to leverage advanced methodologies and technologies, such as genomics, data analytics, and field epidemiology to enhance our understanding of infectious diseases;
  2. Fostering collaborations among researchers, industry partners, academic institution and other stakeholders;
  3. Identifying and securing funding and resources necessary to support both on going and futures research activities;
  4. Facilitating and dissemination of research findings for the benefit of public health, and;
  5. Providing training and development opportunities for researchers and students by fostering a culture of continuous learning.

Topic

• Therapeutic development and international collaboration as a strategy for future pandemic preparedness and response at TIDREC

Summary

• Tick-borne viral diseases ; An emering, Under-Appreciated Threat?

Education

• 2003 ~ 2005 Chosun University Bachelor
• 1997 ~ 1999 Chosun University Master
• 1989 ~ 1995 Chosun University Ph.D

Experience

• 2013 ~ Present Professor, Chosun University
• 2010 ~ 2012 Training at the US Centers for Disease Control and Prevention (CDC)
• 2010 ~ 2013 Associate Professor, Chosun University
• 2006 ~ 2010 Assistant Professor, Chosun University
• 2004 ~ 2006 Full-time lecturer at Chosun University
• 2003 ~ 2004 Seoul National University Hospital Resident
• 2000 ~ 2002 Jeonnam Provincial Office Epidemiological Investigator

Education

• 2017 ~ Present MSc Infectious Diseases Course International Programmes in LONDON SCHOOL of HYGIENE & TROPICAL MEDICINE(LSHTM), UOL, London UK
• 2000 ~ 2003 Ph.D. in Microbiology and Immunology Seoul National University College of Medicine, Seoul South Korea.
• 1994 ~ 1999 M.S. in Microbiology Kyungpook National University College of Science, Daegu South Korea
• 1990 ~ 1994 B.S. in Microbiology Kyungpook National University College of Science, Daegu South Korea

Experience

• 2020 ~ Present rofessor Department of Microbiology Hanyang University College of Medicine, Seoul South Korea
• 2004 ~ 2020 Assistant Professor, Associate Professor, and Professor Department of Microbiology and Immunology Jeju National University College of Medicine, Jeju South Korea
• 2015 ~ 2015>
  2020 ~ Present Visiting Scientist US Army Medical Component-Armed Forces Research Institute of Medical Sciences(AFRIMS) in Bangkok Thailand
• 2014 ~ 2014 Surveillance officer and International Health Regulation (IHR) duty officer(Volunteer, sabbatical year) The Emer- ging Diseases Surveillance and Response(ESR) World Health Organization, Regional Office for the Western Pacific(WPRO) in Manila Philippines
• 2005 ~ 2006 Research fellow Channing Lab. BWH, Harvard Medical School, Boston MA USA
• 2003 ~ 2004 BK21 Postdoc. Department of Microbiology and Immunology Seoul National University College of Medicine, Seoul South Korea
• 2001 ~ 2003 Teaching Assistant Department of Microbiology and Immunology Seoul National University College of Medicine, Seoul South Korea
• 1994 ~ 1997 1st lieutenant Republic of Korea Airforce

Topic

• Strategic vaccination of food-producing animals: A one health strategy for mitigating infectious disease transmission

Summary

• Large-scale food production is common in the U.S., leading to extensive interactions between the environment and food animals. Since the major foodborne pathogens in the U.S., such as Campylobacter and Salmonella, originate from animals, these pathogens enter the food supply chain from animal reservoirs. This underscores the critical connection between food safety and the One Health approach, which integrates human, animal, and environmental health. To mitigate the risk of microbial contamination from these zoonotic pathogens, U.S. regulatory agencies encourage producers to implement comprehensive pre-harvest interventions. For instance, the USDA promotes non-antibiotic strategies, such as vaccination, to reduce pathogen loads in food animals before slaughter. In Europe and Japan, successful reductions in Salmonella infections have been achieved through poultry vaccination. However, effective pre-harvest methods for Campylobacter are currently lacking. Our laboratory has recently developed a live-attenuated Campylobacter vaccine that significantly reduces the bacterial loads in poultry, demonstrating promising potential as an effective pre-harvest intervention strategy.

Topic

• Situation of Viral Zoonotic Diseases in Vietnam

Summary

Topic

• One Health Approaches to Gastrointestinal Tract Infections in South Korea

Summary

• The domestic status and research direction of One Health food poisoning infectious diseases between humans and animals should be approached from the One Health perspective that the health of humans, animals, and the environment are interconnected. In particular, considering the recent increase in companion animals and the increase in food poisoning due to the expansion of eating out and group meals, it is necessary to establish a cooperative system and joint research and development between related ministries. In addition, the emergence and spread of antibiotic-resistant bacteria throughout the ecosystem including humans, animals, and the environment is making the management of food poisoning infectious diseases more difficult, so a joint investigation system between related ministries in the event of food poisoning should be established from the One Health perspective. In order to effectively manage food poisoning infectious diseases, a joint research and development system involving multidisciplinary One Health experts should be established, and strategies for identifying the cause of food poisoning and prevention should be established. In addition to comprehensively managing and sharing information in the human-animal field, strengthening One Health concepts and food poisoning prevention education, it will be necessary to activate surveillance and epidemiological investigations of major food poisoning pathogens, and conduct research to identify the cause and path of occurrence.

Topic

• Current Status of Q fever and the Challenge of Outbreak Preparedness in Korea: One Health Approach to Zoonoses

Summary

• Human Q fever, zoonosis caused by Coxiella burnetii, presents with diverse clinical manifestations, from mild self-limited febrile illnesses to life-threatening complications such as endocarditis or vascular infection. Although the acute Q fever is benign illness with a low mortality rate, a large-scale outbreak of Q fever in the Netherlands could lead to public health concerns such as blood transfusion-related transmission or obstetrical complications in pregnant women. Furthermore, chronic Q fever was developed in <5% of patients with C. burnetii infection. It can become fatal in 5-50% of patients with Chronic Q fever if left untreated. In South Korea, Q fever was designated as a notifiable infectious disease in 2006, and the number of Q fever cases has sharply increased since 2015. Nonetheless, it is still considered a neglected and underrecognized infectious disease. In this lecture, incidence, causes and impact of human Q fever will be presented, and “One Health” approach as countermeasures for preventing zoonotic disease outbreak will also be covered.

Education

• 2017 Chonnam National University, Ph.D
• 2005 Seoul National University College of Medicine, M.M.Sc
• 2000 Seoul National University College of Medicine, M.D.

Experience

• 2023 ~ Present Director, Korea National Institute of Health
• 2020 ~ 2023 Director, Department of Precision Medicine, KNIH
• 2018 ~ 2020 Director, Center for Genome Science, KNIH
• 2017 ~ 2018 Director, Division of Cardiovascular Diseases, KNIH, KCDC
• 2012 ~ 2023 PI, National Research Program for Women’s Health
• 2011 ~ 2014 Team leader, National Center for Medical Information and Knowledge TF
• 2008 ~ 2014 Team leader, Clinical Research Coordination TF
• 2005 ~ 2017 Director, Division of Cardiovascular & Rare Diseases, KNIH, KCDC
• 2002 ~ 2003 Research Associate, Duke University Medical Center, USA
• 2004 ~ 2002 Assistant professor of Cardiology (Dept. of internal medicine)
• 2000 ~ 2005 Assistant professor of Cardiology (Dept. of internal medicine)
• 1998 ~ 2000 Assistant professor, Yonsei Cardiovascular Research Institute
• 1998 ~ 2000 Instructor, Yonsei Cardiovascular Research Institute, Yonsei University College of Medicine
• 1996 ~ 1998 Research Student, Department of Clinical Pathology, Shimane Medical University, Japan
• 1995 ~ 1996 Research fellow, Cardiology division, Yonsei Cardiovascular Center, Yonsei University College of Medicine
• 1990 ~ 1995 Resident, Department of Internal Medicine, Yongdong Severance Hospital